UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004435
Receipt number R000005304
Scientific Title Phase II study of chemoradiotherapy using localized irradiation field for T1-3N0M0 esophageal carcinoma.
Date of disclosure of the study information 2010/10/25
Last modified on 2014/10/24 18:19:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II study of chemoradiotherapy using localized irradiation field for T1-3N0M0 esophageal carcinoma.

Acronym

Phase II study of localized-field chemoradiotherapy for esophageal carcinoma.

Scientific Title

Phase II study of chemoradiotherapy using localized irradiation field for T1-3N0M0 esophageal carcinoma.

Scientific Title:Acronym

Phase II study of localized-field chemoradiotherapy for esophageal carcinoma.

Region

Japan


Condition

Condition

Esophageal carcinoma

Classification by specialty

Gastroenterology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate merit and demerit of localized-irradiation field for early esophageal carcioma.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Overall survival

Key secondary outcomes

Recurrence-free survival,
Incidence of adverse effects


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver Other

Interventions/Control_1

Chemoradiotherapy(CDDP+5FU+60Gy/30fr.)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

- T1-3N0M0 untreated esophageal squamous cell carcinoma
- Negative lymph node metastasis by PET
- Performancestatus 0-1
- 20 - 75 years old
- Sufficient liver and renal functions
- Written informed consent is obtained

Key exclusion criteria

- Multiple or skip lesions
- Prior thoracic irradiation or chemotherapy
- Prior esophageal EMR
- Synchronous malignancies
- Uncontrolled severe complications
- Possibility of pregnancy

Target sample size

36


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kenji Nemoto

Organization

Yamagata University School of Medicine

Division name

Department of Radiation Oncology

Zip code


Address

2-2-2, Iida-nishi, Yamagata city, Yamagata, 990-9585, Japan

TEL

+81-23-628-5386

Email

knemoto@med.id.yamagata-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kenji Nemoto

Organization

Yamagata University School of Medicine

Division name

Department of Radiation Oncology

Zip code


Address

2-2-2, Iida-nishi, Yamagata city, Yamagata, 990-9585, Japan

TEL

+81-23-628-5386

Homepage URL


Email

knemoto@med.id.yamagata-u.ac.jp


Sponsor or person

Institute

Department of Radiation Oncology, Yamagata University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for Scientific Research (A): The Ministry of Education, Culture, Sports, Science and Technology.
Grant-in-Aid: Japanese Radiation Oncology Study Group.

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

山形大学病院(山形県)


Other administrative information

Date of disclosure of the study information

2010 Year 10 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2010 Year 07 Month 24 Day

Date of IRB


Anticipated trial start date

2010 Year 10 Month 01 Day

Last follow-up date

2016 Year 09 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 10 Month 24 Day

Last modified on

2014 Year 10 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005304


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name